Lung cancer patients with MIA have comparable 97.7 percent five-year survival as patients with AIS
Lung cancer patients with minimally invasive adenocarcinoma (MIA) have similar, positive five-year disease-free survival (DFS) and overall survival (OS) rates as patients with adenocarcinoma in-situ (AIS), according to research ...
Oct 30, 2014
0
0